Genetic deletion of Cav3.2 T-type calcium channels abolishes H2S-dependent somatic and visceral pain signaling in C57BL/6 mice

J Pharmacol Sci. 2019 Jul;140(3):310-312. doi: 10.1016/j.jphs.2019.07.010. Epub 2019 Jul 30.

Abstract

We tested whether genetic deletion of Cav3.2 T-type Ca2+ channels abolishes hydrogen sulfide (H2S)-mediated pain signals in mice. In Cav3.2-expressing HEK293 cells, Na2S, an H2S donor, at 100 μM clearly increased Ba2+ currents, as assessed by whole-cell patch-clamp recordings. In wild-type C57BL/6 mice, intraplantar and intracolonic administration of Na2S evoked mechanical allodynia and visceral nociceptive behavior, respectively, which were abolished by TTA-A2, a T-type Ca2+ channel blocker. In Cav3.2-knockout mice of a C57BL/6 background, Na2S caused neither somatic allodynia nor colonic nociception. Our study thus provides definitive evidence for an essential role of Cav3.2 in H2S-dependent somatic and colonic pain.

Keywords: Ca(v)3.2 T-type calcium channel; Hydrogen sulfide; Pain.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, T-Type / genetics*
  • Calcium Channels, T-Type / metabolism*
  • Cell Line
  • HEK293 Cells
  • Humans
  • Hydrogen Sulfide / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Nociceptive Pain / metabolism*
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects*
  • TRPA1 Cation Channel / metabolism
  • Visceral Pain / metabolism*

Substances

  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • TRPA1 Cation Channel
  • Calcium
  • Hydrogen Sulfide